Abstract
Four-stranded tetraplex (“G-quadruplex”) DNA represents a new paradigm for the design of DNA-interactive antitumour drugs, as the formed DNA-drug complexes have been suggested to interfere with critical telomerase function. The unique structural features presented by tetraplex over duplex DNA have stimulated the design of small ligand molecules able to selectively promote the formation and-or stabilisation of such higher-order DNA structures. Current developments in tetraplex-targeted telomerase inhibitors, and importantly their DNA structural selectivity, are explored.
Keywords: DNA Tetraplex, Antitumour Telomerase, nucleic acid biotargets, malignant transformation, covalent fixation processes, chemotherapeutic target, Guanine rich, telomerase activity, isothermal titration calorimetry, stacked G tetrads, mesoporphyrin NMM dye
Mini-Reviews in Medicinal Chemistry
Title: DNA Tetraplex-Binding Drugs Structure-Selective Targeting is Critical for Antitumour Telomerase Inhibition
Volume: 1 Issue: 1
Author(s): Philip J. Perry and Terence C. Jenkins
Affiliation:
Keywords: DNA Tetraplex, Antitumour Telomerase, nucleic acid biotargets, malignant transformation, covalent fixation processes, chemotherapeutic target, Guanine rich, telomerase activity, isothermal titration calorimetry, stacked G tetrads, mesoporphyrin NMM dye
Abstract: Four-stranded tetraplex (“G-quadruplex”) DNA represents a new paradigm for the design of DNA-interactive antitumour drugs, as the formed DNA-drug complexes have been suggested to interfere with critical telomerase function. The unique structural features presented by tetraplex over duplex DNA have stimulated the design of small ligand molecules able to selectively promote the formation and-or stabilisation of such higher-order DNA structures. Current developments in tetraplex-targeted telomerase inhibitors, and importantly their DNA structural selectivity, are explored.
Export Options
About this article
Cite this article as:
Perry J. Philip and Jenkins C. Terence, DNA Tetraplex-Binding Drugs Structure-Selective Targeting is Critical for Antitumour Telomerase Inhibition, Mini-Reviews in Medicinal Chemistry 2001; 1 (1) . https://dx.doi.org/10.2174/1389557013407304
DOI https://dx.doi.org/10.2174/1389557013407304 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Nervous System as a Critical Regulator of Immune Responses Underlying Allergy
Current Pharmaceutical Design Biopharmaceutics and Therapeutic Potential of Engineered Nanomaterials
Current Drug Metabolism Colostral Proline-Rich Polypeptides - Immunoregulatory Properties and Prospects of Therapeutic Use in Alzheimers Disease
Current Alzheimer Research Recent Advances in the Syntheses of Nucleoside Triphosphates
Current Organic Synthesis Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
Current Neuropharmacology Thymic Nurse Cells Participate in Heterotypic Internalization and Repertoire Selection of Immature Thymocytes; Their Removal from the Thymus of Autoimmune Animals May be Important to Disease Etiology
Current Molecular Medicine The Role for Oxidative Stress in Aberrant DNA Methylation in Alzheimer’s Disease
Current Alzheimer Research Synthesis, Structure-Activity Relationship and Biological Activity of Acridine Derivatives as Potent MDR-Reversing Agents
Current Medicinal Chemistry Oncolytic Viruses: Whats Next?
Current Cancer Drug Targets Prothymosin Alpha: An Alarmin and More...
Current Medicinal Chemistry Protein Regulators of Eicosanoid Synthesis: Role in Inflammation
Current Protein & Peptide Science Endocannabinoids and Their Receptors: Physiology, Pathology and Pharmacology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Electrochemical DNA Biosensors in Drug Analysis
Current Pharmaceutical Analysis Role of Natural Killer Cell Activity in the Pathogenesis of Endometriosis
Current Medicinal Chemistry Further Perspectives on Diabetes: NeuroRegulation of Blood Glucose
Neuroscience and Biomedical Engineering (Discontinued) Structures Required of Polyphenols for Inhibiting Advanced Glycation end Products Formation
Current Drug Metabolism NLRP3 Inflammasome Activation Leading to IL-1 – IL-17 Dependent Lung Inflammation and Fibrosis
Current Respiratory Medicine Reviews III. Angiogenesis: Complexity of Tumor Vasculature and Microenvironment
Current Pharmaceutical Design Predicting Drug Metabolism Induction In Silico
Current Topics in Medicinal Chemistry Poly(ADP-ribose): Structure, Physicochemical Properties and Quantification In Vivo, with Special Reference to Poly(ADP-ribose) Binding Protein Modules
Current Protein & Peptide Science